NASDAQ$SYRS

Syros Pharmaceuticals Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Headline financials

Total Revenue

$4.83M

Previous: $2.38M+102.9%
EPS (adj)

-$2.30

Previous: -$3.90+41.0%
Capital Expenditures

-$262K

Previous: -$1.8M+85.4%
Free Cash Flow

-$22.3M

Previous: -$1.55M-1334.7%
Net Income

-$14.2M

Previous: -$17.2M+17.4%
Operating Income

-$20.9M

Previous: -$17.3M-20.8%
Cash & Equivalents

$222M

Previous: $117M+90.1%
Total Assets

$261M

Previous: $161M+61.5%

Revenue & EPS history

Syros · Revenue · Quarterly

$4.83M

Q1 2021+102.9%vs Q1 2020
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+2.5%

Avg return

Earnings day

+2.5%

Avg return

5 days after

-5.0%

Avg return

30 days after

61%

23 / 38 earnings

Positive

+43.9%

Q2 2016

Best reaction

-14.4%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025+0.0%+50.0%+25.0%
Q2 2025+10.0%-45.0%-95.0%
Q1 2025-10.4%-7.6%-40.2%
Q4 2024+14.3%+11.1%-14.3%
Q3 2024-9.6%+0.8%-89.2%
Q2 2024-9.4%-16.9%-73.8%
Q1 2024+8.9%+7.7%+14.6%
Q4 2023-14.4%-19.4%-19.4%
Q3 2023+13.0%+10.8%+61.0%
Q2 2023+1.4%+3.8%+5.2%
Q1 2023+6.8%+20.9%+14.1%
Q4 2022+7.4%+9.8%-27.0%
Q3 2022+0.8%+2.5%-7.0%
Q2 2022-1.5%-2.1%-29.2%
Q1 2022-13.6%-19.3%+19.0%
Q4 2021+2.8%+8.4%-15.3%
Q3 2021-1.4%-4.5%-19.7%
Q2 2021+4.0%+2.0%+17.5%
Q1 2021-5.1%-5.3%+6.9%
Q4 2020-4.6%-1.1%-11.2%
Q3 2020+2.2%+0.2%-6.1%
Q2 2020+8.2%+6.5%-12.1%
Q1 2020+6.6%+1.3%-3.4%
Q4 2019+5.8%-15.4%-2.4%
Q3 2019+5.0%+0.0%-7.4%
Q2 2019+8.3%+5.6%+46.7%
Q1 2019-5.4%-3.2%-18.4%
Q4 2018-8.9%+3.3%+5.8%
Q3 2018+17.9%+22.5%+3.5%
Q2 2018+14.8%+21.7%+17.8%
Q1 2018+2.5%+3.0%+2.6%
Q4 2017+5.0%+6.2%+11.4%
Q3 2017-5.1%-4.9%+1.0%
Q2 2017-7.7%+0.4%-24.7%
Q1 2017+12.2%+15.7%+16.4%
Q4 2016-8.2%-4.1%-4.8%
Q3 2016+0.4%-2.9%+11.8%
Q2 2016+43.9%+33.7%+50.4%
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro